Interstitial fluid pressure, fraction of necrotic tumor tissue, and tumor cell density in human melanoma xenografts

Acta Oncologica

Volumn 37, Issue 3, 1998, Pages 291-297

  Tufto, Ingunn ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CELL HETEROGENEITY; EXPERIMENTAL NEOPLASM; FLOW; HISTOPATHOLOGY; IMAGE ANALYSIS; MELANOMA; MICROPHOTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE NECROSIS; TISSUE PRESSURE; XENOGRAFT;

ANIMALS; CELL COUNT; EXTRACELLULAR SPACE; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; NECROSIS; NEOPLASM TRANSPLANTATION; PRESSURE; TUMOR CELLS, CULTURED;

EID: 0031749029     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698429603     Document Type: Article

References (30)

1. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039-51.
2. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65.
3. Taginawa N, Kanazawa T, Satomura K, Hikasa Y, Hashida M, Muranishi S, Sezaki H. Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 1981; 14: 149-54.
4. Jain RK, Baxter LT. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 1988; 48: 7022-32.
5. Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 1990; 50: 4478-84.
6. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992; 52: 5110-4.
7. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 31: 288-305.
8. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48: 2641-58.
9. Netti PA, Roberge S, Boucher Y, Baxter LT, Jain RK. Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc Res 1996; 52: 27-46.
10. Znati CA, Rosenstein M, Boucher Y, Epperly MW, Bloomer WD, Jain RK. Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res 1996; 56: 964-8.
11. Boucher Y, Kirkwood JM, Opacic D, Desantis M, Jain RK. Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res 1991; 51: 6691-4.
12. Tufto I, Rofstad EK. Interstitial fluid pressure in human melanoma xenografts. Relationship to fractional tumor water content, tumor size, and tumor volume-doubling time. Acta Oncol 1995; 34: 361-5.
13. Less JR, Posner MC, Boucher Y, Borochovitz D, Wolmark N, Jain RK. Interstitial hypertension in human breast and colorectal tumors. Cancer Res 1992; 52: 6371-4.
14. Curti BD, Urba WJ, Alvord WG, et al. Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res 1993; 53: 2204-7.
15. Sevick EM, Jain RK. Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. Cancer Res 1989; 49: 3506-12.
16. Sevick EM, Jain RK. Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. Cancer Res 1989; 49: 3513-9.
17. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6: 559-93.
18. Cobb LM. Intratumour factors influencing the access of antibody to tumour cells. Cancer Immunol Immunother 1989; 28: 235-40.
19. Boucher Y, Salehi H, Witwer B, Harsh IV GR, Jain RK. Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br J Cancer 1997; 75: 829-36.
20. Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990; 9: 253-66.
21. Rofstad EK. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br J Cancer 1994; 70: 804-12.
22. Fadnes HO, Reed RK, Aukland K. Interstitial fluid pressure in rats measured with a modified wick technique. Microvasc Res 1977; 14: 27-36.
23. Weibel ER. Stereological methods. London: Academic Press, 1979.
24. Solesvik OV, Rofstad EK, Brustad T. Vascular structure of five human malignant melanomas grown in athymic nude mice. Br J Cancer 1982; 46: 557-67.
25. Brammer I, Jung H. Morphometry of irradiated tumors. In: Kallmann RF, ed. Rodent tumor models in experimental cancer therapy. Elmsford: Pergamon Press, 1987: 97-100.
26. Lee I, Boucher Y, Jain RK. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res 1992; 52: 3237-40.
27. Roh HD, Boucher Y, Kalnicki S, Buchsbaum R, Bloomer WD, Jain RK. Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res 1991; 51: 6695-8.
28. Hori K, Suzuki M, Abe I, Saito S. Increased tumor tissue pressure in association with the growth of rat tumors. Jpn J Cancer Res 1986; 77: 65-73.
29. Jain RK, Wei J. Dynamics of drug transport in solid tumors: distributed parameter model. J Bioeng 1977; 1: 313-29.
30. Iozza RV. Proteoglycans and the intercellular tumor matrix. Curr Topics Pathol 1987; 77: 207-21.